Siobhan sells SNY 53.5: Merrimack Falls Steeply as Sanofi Returns Oncology Drug Rights - Analyst Blog
Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) fell 11.28% after the company announced that Sanofi (NYSE: SNY) will give up its development and commercialization rights to oncology candidate, MM-121. Sanofi decided to return the rights to MM-121 to ... ...
39 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home